Abstract:Accumulating evidence supports that gut dysbiosis may relate to various liver diseases. Alcoholics with high intestinal permeability had a decrease in the abundance of Ruminnococcus. Intestinal dysmotility, increased gastric pH, and altered immune responses in addition to environmental and genetic factors are likely to cause alcohol-associated gut microbial changes. Alcohol-induced dysbiosis may be associated with gut barrier dysfunction, as microbiota and their products modulate barrier function by affecting epithelial pro-inflammatory responses and mucosal repair functions. High levels of plasma endotoxin are detected in alcoholics, in moderate fatty liver to advanced cirrhosis. Decreased abundance of Faecalibacterium prausnitzii, an anti-inflammatory commensal, stimulating IL-10 secretion and inhibiting IL-12 and interferon-γ expression. Proteobacteria, Enterobacteriaceae, and Escherichia were reported to be increased in NAFLD (nonalcoholic fatty liver disease) patients. Increased abundance of fecal Escherichia to elevated blood alcohol levels in these patients and gut microbiota enriched in alcohol-producing bacteria produce more alcohol (alcohol hypothesis). Some undetermined pathological sequences related to gut dysbiosis may facilitate energy-producing and proinflammatory conditions for the progression of NAFLD. A shortage of autochthonous non-pathogenic bacteria and an overgrowth of potentially pathogenic bacteria are common findings in cirrhotic patients. The ratio of the amounts of beneficial autochthonous taxa (Lachnospiraceae + Ruminococaceae + Veillonellaceae + Clostridiales Incertae Sedis XIV) to those of potentially pathogenic taxa (Enterobacteriaceae + Bacteroidaceae) was low in those with early death and organ failure. Cirrhotic patients with decreased microbial diversity before liver transplantation were more likely to develop post-transplant infections and cognitive impairment related to residual dysbiosis. Patients with PSC had marked reduction of bacterial diversity. Enterococcus and Lactobacillus were increased in PSC patients (without liver cirrhosis.) Treatment-naive PBC patients were associated with altered composition and function of gut microbiota, as well as a lower level of diversity. As serum anti-gp210 antibody has been considered as an index of disease progression, relatively lower species richness and lower abundance of Faecalibacterium spp. in gp210-positive patients are interesting. The dysbiosis-induced altered bacterial metabolites such as a hepatocarcinogenesis promotor DCA, together with a leaky gut and bacterial translocation. Gut protective Akkermansia and butyrate-producing genera were decreased, while genera producing-lipopolysaccharide were increased in early hepatocellular carcinoma (HCC) patients.

Innovation Waves, Investor Sentiment, and Mergers

The Role of Gut Bacteria and Fungi in Alcohol-Associated Liver Disease

Alcohol or Gut Microbiota: Who Is the Guilty?

Auditory spatial response areas of single neurons and space representation in the cerebellum of echo locating bats

Repair of DNA damage after exposure to 4-nitroquinoline-1-oxide in heterokaryons derived from xeroderma pigmentosum cells.

Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice

Gut microbiota in alcohol-related liver disease: pathophysiology and gut-brain cross talk

Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?

Gut microbiota-modulating agents in alcoholic liver disease: Links between host metabolism and gut microbiota

Probiotics and Alcoholic Liver Disease: Treatment and Potential Mechanisms

Role of Microbiota-Derived Metabolites in Alcoholic and Non-Alcoholic Fatty Liver Diseases

Drugging the Gut Microbiome for the Treatment of Alcohol‐Induced Liver Injury

Characteristics of microbiome-derived metabolomics according to the progression of alcoholic liver disease

Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice

Vertical transmission of dengue-2 virus through Aedes albopictus mosquitoes.

Gut Microbiota: Target for Modulation of Gut-Liver-Adipose Tissue Axis in Ethanol-Induced Liver Disease

Pathogenic mechanisms and regulatory factors involved in alcoholic liver disease

Dietary fiber alleviates alcoholic liver injury via Bacteroides acidifaciens and subsequent ammonia detoxification

Application of quantum descriptors for predicting adsorption performance of starch and cyclodextrin adsorbents.

Intestinal HIF-1α Deletion Exacerbates Alcoholic Liver Disease by Inducing Intestinal Dysbiosis and Barrier Dysfunction

Bacillus coagulans Regulates Gut Microbiota and Ameliorates the Alcoholicassociated Liver Disease in Mice